Loridapa-Trio Tablet ER

Overview Loridapa-Trio Tablet ER

GlucoTriad XR tablets combine medications to manage blood glucose. This formulation, used alongside diet and exercise, improves glycemic control in adults with type 2 diabetes. It enhances insulin effectiveness, thus reducing blood sugar. GlucoTriad XR can be ingested with or without food, but consistent daily timing is recommended. Dosage is determined by your physician; discontinuation without medical advice may elevate blood sugar, increasing risks such as kidney complications and vision impairment. This medication complements a comprehensive treatment plan including a healthy diet, regular physical activity, and weight management as directed by your doctor. Common side effects include upper respiratory tract infections, sore throat, nasal congestion, and urinary tract infections. Adequate hydration helps prevent dehydration. Genital fungal infections are a possibility; good hygiene is preventative. Before starting GlucoTriad XR, discuss any kidney or liver issues, urinary tract infections, or diuretic use with your doctor. Pregnant or lactating individuals should seek medical counsel prior to use. Limit alcohol consumption, as it may exacerbate side effects. Regular blood glucose monitoring is crucial while using this medication.

Primary Ingredients of Loridapa-Trio Tablet ER

No text was provided to rewrite.

Uses of Loridapa-Trio Tablet ER

Managing type 2 diabetes

Major Benefits of Loridapa-Trio Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for Loridapa-Trio Extended-Release tablets. Ingest the tablets whole; avoid chewing, crushing, or breaking them. While Loridapa-Trio ER may be administered with or without food, consistent timing is recommended for optimal results.

Common Side effects of Loridapa-Trio Tablet ER:

• Diarrhea
• Nausea
• Vomiting
• Flatulence
• Polyuria
• Dyslipidemia
• Genital fungal infection
• Nasopharyngitis (inflammation of the throat and nasal passages)
• Urinary tract infection
• Headache
• Hypoglycemia (low blood glucose level)
• Conjunctivitis
• Cough

How to use Loridapa-Trio Tablet ER:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Loridapa-Trio Extended-Release Tablets can be administered with or without food, though consistent timing is recommended.

How Loridapa-Trio Tablet ER works:

Loridapa-Trio ER tablets contain a triple-action antidiabetic formulation. Dapagliflozin works by enhancing glucose elimination via the urine, thereby lowering blood sugar. Metformin reduces glucose absorption from ingested food and hepatic glucose production. Additionally, it amplifies the body's insulin sensitivity, improving the regulation of blood glucose. Sitagliptin manages blood sugar by boosting incretin levels, stimulating the pancreas to release more insulin and suppressing excess hepatic glucose production.

What if you forget to take Loridapa-Trio Tablet ER :

NA